Jilin Zixin Pharmaceutical Co., Ltd. (002118)

Jilin Zixin Pharmaceutical Co., Ltd. (002118)

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the company") was established in May 1998. It is a high-tech group listed company with Chinese patent medicine industry, ginseng industry and gene sequencer industry as its core business, integrating production, sales, scientific research and development of high value-added medicinal animal and plant breeding (listed on Shenzhen Stock Exchange on March 2, 2007), The stock is abbreviated as "Zixin pharmaceutical", and the stock code is 002118).

Since its establishment, the company has developed for 20 years. At present, the company has 24 wholly-owned and holding subsidiaries and grandchildren, and 1 joint-stock financial company. They are respectively located in the south, middle and east foot of Changbai Mountains, Hong Kong, the United States, the Netherlands and other places. After more than 10 years of rapid development, the enterprise scale has been expanding, and the output value, profits and taxes have been rising year after year. The company has been rated as a major taxpayer of non-public economy in Jilin Province; Small giant enterprises; Top 100 non-public enterprises; Top 100 Chinese medicine enterprises in China; State level high-tech enterprises; National Youth Civilization enterprise; The national key leading enterprises of agricultural industrialization have gradually formed a big health industry chain integrated management mode with "Zixin characteristics".

>> tungsten carbide rings silver